Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the close of a EUR 90 million Series A funding round, bringing the total amount raised by the company to EUR 116 million.
Additionally, investors should not forget that J.P. Morgan's exposure to macroeconomic cycles leaves it vulnerable to credit quality deterioration and reduced loan demand if economic growth falters.
Morgan Stanley stays bullish on Apple going into 2025, citing accelerated iPhone replacement cycles, double-digit services ... Among active stocks. J.P. Morgan upgraded Okta (OKTA) to Overweight ...
The American industrialist and financier John Pierpont Morgan (1837-1913) was a serious collector of objects, books, and ephemera for most of his life, and his avidity and the diversity of the mat ...
We may receive commissions on purchases made from our chosen links. Get up to $700 when you open and fund a J.P. Morgan Self-Directed Investing account with qualifying new money. Open an account ...